Mount Sinai Hospital implements CloudMedx AI for heart disease treatment

New York City-based Mount Sinai Hospital has selected the clinical AI platform CloudMedx to help manage patients at risk for congestive heart failure.

Advertisement

CloudMedx provides predictions of patient risk for congestive heart failure and triages patients based on their likelihood to be readmitted to the hospital in a certain amount of time. These predictive insights help physicians construct personalized treatment guidelines to improve a patient’s outcome before they fall ill. The AI platform also collects patient data from devices at their homes, to remotely monitor patient health.

“Through our clinical models, we can predict who are the high risk patients, would need more follow ups, more hand holding and more care interventions,” said Tashfeen Suleman, CEO of CloudMedx. “Based on these insights, we can equip case managers with insights to follow up with the necessary interventions that ensure a smooth transition for these patients back into their own homes.”

More articles on health IT:
ONC issues final rule on Health IT Certification Program
Survey: Healthcare attorneys believe industry at high risk for cyberattacks
HHS finalizes MACRA Quality Payment Program, includes emphasis on health IT

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.